Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.

Svahn F, Paulsson JO, Stenman A, Fotouhi O, Mu N, Murtha TD, Korah R, Carling T, Bäckdahl M, Wang N, Juhlin CC, Larsson C.

Int J Mol Med. 2018 Sep;42(3):1675-1683. doi: 10.3892/ijmm.2018.3735. Epub 2018 Jun 20.

PMID:
29956721
2.

Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.

Wang N, Kjellin H, Sofiadis A, Fotouhi O, Juhlin CC, Bäckdahl M, Zedenius J, Xu D, Lehtiö J, Larsson C.

Oncotarget. 2016 Apr 19;7(16):21332-46. doi: 10.18632/oncotarget.7237.

3.

HRAS mutation prevalence and associated expression patterns in pheochromocytoma.

Stenman A, Welander J, Gustavsson I, Brunaud L, Bäckdahl M, Söderkvist P, Gimm O, Juhlin CC, Larsson C.

Genes Chromosomes Cancer. 2016 May;55(5):452-9. doi: 10.1002/gcc.22347. Epub 2016 Feb 23.

4.

Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.

Åkerström T, Willenberg HS, Cupisti K, Ip J, Backman S, Moser A, Maharjan R, Robinson B, Iwen KA, Dralle H, D Volpe C, Bäckdahl M, Botling J, Stålberg P, Westin G, Walz MK, Lehnert H, Sidhu S, Zedenius J, Björklund P, Hellman P.

Endocr Relat Cancer. 2015 Oct;22(5):735-44. doi: 10.1530/ERC-15-0321.

PMID:
26285814
5.

Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.

Juhlin CC, Stenman A, Haglund F, Clark VE, Brown TC, Baranoski J, Bilguvar K, Goh G, Welander J, Svahn F, Rubinstein JC, Caramuta S, Yasuno K, Günel M, Bäckdahl M, Gimm O, Söderkvist P, Prasad ML, Korah R, Lifton RP, Carling T.

Genes Chromosomes Cancer. 2015 Sep;54(9):542-54. doi: 10.1002/gcc.22267. Epub 2015 May 29.

6.

Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

Juhlin CC, Goh G, Healy JM, Fonseca AL, Scholl UI, Stenman A, Kunstman JW, Brown TC, Overton JD, Mane SM, Nelson-Williams C, Bäckdahl M, Suttorp AC, Haase M, Choi M, Schlessinger J, Rimm DL, Höög A, Prasad ML, Korah R, Larsson C, Lifton RP, Carling T.

J Clin Endocrinol Metab. 2015 Mar;100(3):E493-502. doi: 10.1210/jc.2014-3282. Epub 2014 Dec 9.

7.

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.

Liu T, Brown TC, Juhlin CC, Andreasson A, Wang N, Bäckdahl M, Healy JM, Prasad ML, Korah R, Carling T, Xu D, Larsson C.

Endocr Relat Cancer. 2014 May 6;21(3):427-34. doi: 10.1530/ERC-14-0016. Print 2014 Jun.

8.

Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma.

Wang N, Xu D, Sofiadis A, Höög A, Vukojević V, Bäckdahl M, Zedenius J, Larsson C.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1571-9. doi: 10.1210/jc.2014-1158. Epub 2014 Apr 23.

9.

Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma.

Welander J, Andreasson A, Brauckhoff M, Bäckdahl M, Larsson C, Gimm O, Söderkvist P.

Endocr Relat Cancer. 2014 Jun;21(3):495-504. doi: 10.1530/ERC-13-0384. Epub 2014 Apr 16.

PMID:
24741025
10.

Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.

Welander J, Andreasson A, Juhlin CC, Wiseman RW, Bäckdahl M, Höög A, Larsson C, Gimm O, Söderkvist P.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1352-60. doi: 10.1210/jc.2013-4375. Epub 2014 Apr 2.

11.

MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas.

Velázquez-Fernández D, Caramuta S, Özata DM, Lu M, Höög A, Bäckdahl M, Larsson C, Lui WO, Zedenius J.

Eur J Endocrinol. 2014 Mar 8;170(4):583-91. doi: 10.1530/EJE-13-0817. Print 2014 Apr.

PMID:
24446485
12.

Role of SDHAF2 and SDHD in von Hippel-Lindau associated pheochromocytomas.

Kugelberg J, Welander J, Schiavi F, Fassina A, Bäckdahl M, Larsson C, Opocher G, Söderkvist P, Dahia PL, Neumann HP, Gimm O.

World J Surg. 2014 Mar;38(3):724-32. doi: 10.1007/s00268-013-2373-2.

PMID:
24322175
13.

The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas.

Andreasson A, Kiss NB, Caramuta S, Sulaiman L, Svahn F, Bäckdahl M, Höög A, Juhlin CC, Larsson C.

Epigenetics. 2013 Dec;8(12):1347-54. doi: 10.4161/epi.26686. Epub 2013 Oct 22.

14.

Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma.

Caramuta S, Lee L, Ozata DM, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C, Lui WO.

Endocr Relat Cancer. 2013 Jul 4;20(4):551-64. doi: 10.1530/ERC-13-0098. Print 2013 Aug.

15.

Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation.

Kiss NB, Muth A, Andreasson A, Juhlin CC, Geli J, Bäckdahl M, Höög A, Wängberg B, Nilsson O, Ahlman H, Larsson C.

Endocr Relat Cancer. 2013 Feb 18;20(1):65-78. doi: 10.1530/ERC-12-0267. Print 2013 Feb.

16.

Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas.

Welander J, Larsson C, Bäckdahl M, Hareni N, Sivlér T, Brauckhoff M, Söderkvist P, Gimm O.

Hum Mol Genet. 2012 Dec 15;21(26):5406-16. doi: 10.1093/hmg/dds402. Epub 2012 Sep 24.

PMID:
23010473
17.

Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.

Åkerström T, Crona J, Delgado Verdugo A, Starker LF, Cupisti K, Willenberg HS, Knoefel WT, Saeger W, Feller A, Ip J, Soon P, Anlauf M, Alesina PF, Schmid KW, Decaussin M, Levillain P, Wängberg B, Peix JL, Robinson B, Zedenius J, Bäckdahl M, Caramuta S, Iwen KA, Botling J, Stålberg P, Kraimps JL, Dralle H, Hellman P, Sidhu S, Westin G, Lehnert H, Walz MK, Åkerström G, Carling T, Choi M, Lifton RP, Björklund P.

PLoS One. 2012;7(7):e41926. doi: 10.1371/journal.pone.0041926. Epub 2012 Jul 27.

18.

Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution.

Segerhammar I, Larsson C, Nilsson IL, Bäckdahl M, Höög A, Wallin G, Foukakis T, Zedenius J.

J Surg Oncol. 2012 Dec;106(8):981-6. doi: 10.1002/jso.23177. Epub 2012 Jun 4.

PMID:
22674491
19.

The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.

Özata DM, Caramuta S, Velázquez-Fernández D, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C, Lui WO.

Endocr Relat Cancer. 2011 Oct 27;18(6):643-55. doi: 10.1530/ERC-11-0082. Print 2011 Oct.

20.

Recurrent genomic alterations in benign and malignant pheochromocytomas and paragangliomas revealed by whole-genome array comparative genomic hybridization analysis.

Sandgren J, Diaz de Ståhl T, Andersson R, Menzel U, Piotrowski A, Nord H, Bäckdahl M, Kiss NB, Brauckhoff M, Komorowski J, Dralle H, Hessman O, Larsson C, Akerström G, Bruder C, Dumanski JP, Westin G.

Endocr Relat Cancer. 2010 Jun 3;17(3):561-79. doi: 10.1677/ERC-09-0310. Print 2010 Sep.

PMID:
20410162
21.

Preoperative 99Tc(m)-sestamibi scintigraphy with SPECT localizes most pathologic parathyroid glands.

Lindqvist V, Jacobsson H, Chandanos E, Bäckdahl M, Kjellman M, Wallin G.

Langenbecks Arch Surg. 2009 Sep;394(5):811-5. doi: 10.1007/s00423-009-0536-2. Epub 2009 Jul 4.

PMID:
19578871
22.

Transcriptional profiling enables molecular classification of adrenocortical tumours.

Laurell C, Velázquez-Fernández D, Lindsten K, Juhlin C, Enberg U, Geli J, Höög A, Kjellman M, Lundeberg J, Hamberger B, Larsson C, Nilsson P, Bäckdahl M.

Eur J Endocrinol. 2009 Jul;161(1):141-52. doi: 10.1530/EJE-09-0068. Epub 2009 May 1.

PMID:
19411298
23.

Malignant Fibrous Histiocytoma, Aggressive Fibromatosis and Benign Fibrous Tumors Express mRNA for the Metalloproteinase Inducer EMMPRIN and the Metalloproteinases MMP-2 and MT1-MMP.

Ahlén J, Enberg U, Larsson C, Larsson O, Frisk T, Brosjö O, Rosen A, Bäckdahl M.

Sarcoma. 2001;5(3):143-9. doi: 10.1080/13577140120048601.

24.

Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.

Kiss NB, Geli J, Lundberg F, Avci C, Velazquez-Fernandez D, Hashemi J, Weber G, Höög A, Ekström TJ, Bäckdahl M, Larsson C.

Endocr Relat Cancer. 2008 Jun;15(2):609-21. doi: 10.1677/ERC-07-0285.

PMID:
18509008
25.

Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior.

Geli J, Kiss N, Karimi M, Lee JJ, Bäckdahl M, Ekström TJ, Larsson C.

Clin Cancer Res. 2008 May 1;14(9):2551-9. doi: 10.1158/1078-0432.CCR-07-1867.

26.

Operation for primary hyperparathyroidism: the new versus the old order. A randomised controlled trial of preoperative localisation.

Aarum S, Nordenström J, Reihnér E, Zedenius J, Jacobsson H, Danielsson R, Bäckdahl M, Lindholm H, Wallin G, Hamberger B, Farnebo LO.

Scand J Surg. 2007;96(1):26-30.

PMID:
17461308
27.

The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.

Geli J, Kiss N, Lanner F, Foukakis T, Natalishvili N, Larsson O, Kogner P, Höög A, Clark GJ, Ekström TJ, Bäckdahl M, Farnebo F, Larsson C.

Endocr Relat Cancer. 2007 Mar;14(1):125-34.

PMID:
17395981
28.

Predictors of outcome in patients with papillary thyroid carcinoma.

Kjellman P, Zedenius J, Lundell G, Bäckdahl M, Farnebo LO, Hamberger B, Larsson C, Wallin G.

Eur J Surg Oncol. 2006 Apr;32(3):345-52. Epub 2006 Feb 3.

PMID:
16459050
29.

Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy.

Velázquez-Fernández D, Laurell C, Geli J, Höög A, Odeberg J, Kjellman M, Lundeberg J, Hamberger B, Nilsson P, Bäckdahl M.

Surgery. 2005 Dec;138(6):1087-94.

PMID:
16360395
30.

Nimodipine and microsurgery induced recovery of the vocal cord after recurrent laryngeal nerve resection.

Mattsson P, Björck G, Remahl S, Bäckdahl M, Hamberger B, Hydman J, Svensson M.

Laryngoscope. 2005 Oct;115(10):1863-5.

PMID:
16222210
31.

Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH.

Jarbo C, Buckley PG, Piotrowski A, Mantripragada KK, Benetkiewicz M, Diaz de Ståhl T, Langford CF, Gregory SG, Dralle H, Gimm O, Bäckdahl M, Geli J, Larsson C, Westin G, Akerström G, Dumanski JP.

Int J Cancer. 2006 Mar 1;118(5):1159-64.

32.

Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas.

Geli J, Nord B, Frisk T, Edström Elder E, Ekström TJ, Carling T, Bäckdahl M, Larsson C.

Int J Oncol. 2005 May;26(5):1385-91.

PMID:
15809732
33.

[Many dermatologists can also perform common facial surgery].

Bäckdahl M, Larkö O, Persson B, Wennberg AM, Bäck O, Bjellerup M.

Lakartidningen. 2003 Jun 26;100(26-27):2315. Swedish. No abstract available.

PMID:
12872382
34.

KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.

Elder EE, Xu D, Höög A, Enberg U, Hou M, Pisa P, Gruber A, Larsson C, Bäckdahl M.

Mod Pathol. 2003 Mar;16(3):246-55.

35.

Loss of heterozygosity on the short arm of chromosome 1 in pheochromocytoma and abdominal paraganglioma.

Edström Elder E, Nord B, Carling T, Juhlin C, Bäckdahl M, Höög A, Larsson C.

World J Surg. 2002 Aug;26(8):965-71. Epub 2002 Jun 6.

PMID:
12045857
36.

In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17.

Enberg U, Farnebo LO, Wedell A, Gröndal S, Thorén M, Grimelius L, Kjellman M, Bäckdahl M, Hamberger B.

World J Surg. 2001 Jul;25(7):957-66.

PMID:
11572038
37.

Genetic background of adrenocortical tumor development.

Kjellman M, Larsson C, Bäckdahl M.

World J Surg. 2001 Jul;25(7):948-56. Review.

PMID:
11572037
38.

Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas.

Edström E, Frisk T, Farnebo F, Höög A, Bäckdahl M, Larsson C.

Int J Mol Med. 2000 Oct;6(4):469-74.

PMID:
10998441
39.

Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology.

Edström E, Mahlamäki E, Nord B, Kjellman M, Karhu R, Höög A, Goncharov N, Teh BT, Bäckdahl M, Larsson C.

Am J Pathol. 2000 Feb;156(2):651-9.

40.
41.

Expression of matrix metalloproteinase gelatinase A messenger ribonucleic acid in parathyroid carcinomas.

Farnebo F, Svensson A, Thompson NW, Bäckdahl M, Grimelius L, Larsson C, Farnebo LO, Sandelin K.

Surgery. 1999 Dec;126(6):1183-7.

PMID:
10598205
42.

No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours.

Kjellman M, Holst M, Bäckdahl M, Larsson C, Farnebo LO, Wedell A.

Clin Endocrinol (Oxf). 1999 Mar;50(3):343-6.

PMID:
10435060
43.

Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.

Kjellman M, Roshani L, Teh BT, Kallioniemi OP, Höög A, Gray S, Farnebo LO, Holst M, Bäckdahl M, Larsson C.

J Clin Endocrinol Metab. 1999 Feb;84(2):730-5.

PMID:
10022445
44.

Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA: expressed in adrenocortical cancers but not in adenomas.

Kjellman M, Enberg U, Höög A, Larsson C, Holst M, Farnebo LO, Sato H, Bäckdahl M.

World J Surg. 1999 Mar;23(3):237-42.

PMID:
9933692
45.

A rapid method for DNA extraction from fine-needle aspiration biopsies of thyroid tumors, and subsequent RET mutation analysis.

Zedenius J, Dwight T, Robinson BG, Delbridge L, Bäckdahl M, Wallin G, Larsson C, Weber G.

Cancer Detect Prev. 1998;22(6):544-8.

PMID:
9824378
46.

Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates.

Aogi K, Kitahara K, Buley I, Backdahl M, Tahara H, Sugino T, Tarin D, Goodison S.

Clin Cancer Res. 1998 Aug;4(8):1965-70.

47.

Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism.

Farnebo F, Enberg U, Grimelius L, Bäckdahl M, Schalling M, Larsson C, Farnebo LO.

J Clin Endocrinol Metab. 1997 Oct;82(10):3481-6.

PMID:
9329389
48.

Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.

Kjellman M, Kallioniemi OP, Karhu R, Höög A, Farnebo LO, Auer G, Larsson C, Bäckdahl M.

Cancer Res. 1996 Sep 15;56(18):4219-23.

49.

Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors.

Zedenius J, Wallin G, Svensson A, Bovèe J, Höög A, Bäckdahl M, Larsson C.

Hum Genet. 1996 Mar;97(3):299-303.

PMID:
8786068
50.

Alterations of p53 and expression of WAF1/p21 in human thyroid tumors.

Zedenius J, Larsson C, Wallin G, Bäckdahl M, Aspenblad U, Höög A, Børresen AL, Auer G.

Thyroid. 1996 Feb;6(1):1-9.

PMID:
8777377

Supplemental Content

Loading ...
Support Center